AMPK–SQSTM1 Feedback Loop Drives Dual Stress Response in Cancer

Study Background and Research Question

The tumor microenvironment is characterized by chronic inflammation, nutrient deprivation, and oxidative stress, all of which present significant adaptive challenges for cancer cells. Non-small cell lung cancer (NSCLC) frequently harbors co-occurring mutations in STK11/LKB1 and KEAP1, leading to altered metabolic and redox regulation. Understanding how these genetic disruptions interact to shape cellular stress responses is essential for designing targeted cancer therapies. The reference study by Choi et al. (AUTOPHAGY 2024) addresses this by investigating the regulatory crosstalk between the serine/threonine kinase STK11-activated AMPK pathway and the KEAP1–NFE2L2/NRF2 antioxidant axis during metabolic stress.

Key Innovation from the Reference Study

The central innovation of this work is the discovery of a double-positive feedback loop between AMP-activated protein kinase (AMPK) and the selective autophagy adaptor SQSTM1/p62. This loop enables the dual activation of AMPK and the transcription factor NFE2L2/NRF2 under metabolic stress, thereby synergistically enhancing the antioxidant capacity of cancer cells. This mechanism clarifies why co-mutations in STK11/LKB1 and KEAP1 frequently co-occur in NSCLC and how such genetic backgrounds confer metabolic resilience and tumor growth advantages under stress.

Methods and Experimental Design Insights

Choi et al. combined molecular genetics, biochemical assays, and cell biological approaches in human NSCLC cells and mouse embryonic fibroblasts (MEFs). Key methodologies included:

• Genetic manipulation of STK11, KEAP1, SQSTM1/p62, and related pathway components via knockdown, knockout, and overexpression.
• Induction of metabolic stress through nutrient (glucose) deprivation and pharmacological inhibitors.
• Assessment of protein phosphorylation and expression by immunoblotting, with site-directed mutagenesis to dissect functional consequences of SQSTM1 phosphorylation at S24 and S226.
• Autophagic flux measurement and KEAP1 degradation analysis to link autophagy with pathway activation.
• ROS quantification and antioxidant response assays to connect pathway activation with cellular redox state.
• Application of lysosomal pH modulators and calcium signaling disruptors to probe upstream regulatory events.

This multifaceted approach allowed dissection of both the direct feedback between AMPK and SQSTM1 and the broader consequences for antioxidant defense and cell survival under metabolic challenge.

Core Findings and Why They Matter

The study identified several mechanistic steps forming the AMPK–SQSTM1 feedback loop:

• Metabolic stress (e.g., glucose deprivation) increases SQSTM1 expression and phosphorylation, which are essential for activating both NFE2L2 and AMPK.
• Phosphorylated SQSTM1 promotes autophagic degradation of KEAP1, relieving NFE2L2 inhibition and boosting antioxidant gene expression.
• Simultaneously, SQSTM1 facilitates the assembly of the AXIN–STK11–AMPK complex on lysosomal membranes, promoting AMPK activation.
• AMPK activity, in turn, is required for the metabolic stress-induced expression and phosphorylation of SQSTM1, closing the positive feedback loop.
• Upstream regulators include PPP2/PP2A-dependent dephosphorylation of TFEB/TFE3 (triggered by lysosomal deacidification and Ca²⁺ release) and MAP3K7/TAK1-mediated phosphorylation of SQSTM1, both modulated by ROS and lysosomal pH.
• Importantly, phosphorylation of SQSTM1 at S24 and S226 was necessary for the dual activation of AMPK and NFE2L2. This feedback loop was disrupted by lactic acid supplementation, which neutralizes lysosomal pH and halts the stress response.

Functionally, this integrated mechanism enables cancer cells to simultaneously enhance energy sensing (AMPK) and antioxidant defenses (NFE2L2) under metabolic adversity. This dual activation likely confers a survival advantage in the nutrient- and oxygen-poor tumor microenvironment, explaining the selective pressure for concurrent STK11 and KEAP1 mutations. The findings have implications for targeted therapies aiming to disrupt this adaptive circuit.

Comparison with Existing Internal Articles

The feedback loop described by Choi et al. intersects with several domains of stress signaling and autophagy research, as highlighted in related internal resources. For example, the article "Thapsigargin as a Precision Stress Modulator" discusses the use of SERCA pump inhibitors such as Thapsigargin to induce ER stress and dissect integrated stress responses. While Thapsigargin primarily disrupts intracellular calcium homeostasis—rapidly increasing cytosolic Ca²⁺ and triggering ER stress—it is also widely used to study pathways involving autophagy, oxidative stress, and apoptosis. The reference study's identification of lysosomal Ca²⁺ release as a regulatory event upstream of SQSTM1 activation suggests that pharmacological SERCA inhibition could be a valuable tool for further probing the AMPK–SQSTM1–NFE2L2 axis.

Similarly, "Thapsigargin as a Strategic Lever in Translational Research" contextualizes the utility of precise SERCA inhibition for modeling neurodegenerative disease and apoptosis mechanisms, both of which are relevant to the stress adaptation pathways uncovered in the Choi et al. study. These resources offer practical guidance for experimental design in calcium signaling pathway analysis and endoplasmic reticulum stress research, complementing the mechanistic insights presented in the reference paper.

Limitations and Transferability

While the study provides a comprehensive mechanistic framework, several limitations should be considered. Most experiments were conducted in established cell lines or MEFs, which may not fully recapitulate the complexity of in vivo tumor environments. The reliance on genetic and pharmacological manipulations can introduce off-target effects, and the precise contribution of each signaling node (e.g., specific SQSTM1 phosphorylation sites) may vary across cancer types. Moreover, although the study demonstrates the feedback loop's existence and functional importance in NSCLC models, its universality in other tumor contexts or normal tissues remains to be validated. Translation to clinical strategies will require further investigation into the safety and specificity of targeting this axis.

Protocol Parameters

• Metabolic stress induction: Glucose deprivation or use of metabolic inhibitors to mimic tumor environmental stress.
• SQSTM1/p62 modulation: Site-directed mutagenesis of S24 and S226 or siRNA-mediated knockdown for functional studies.
• Lysosomal Ca²⁺ manipulation: Application of SERCA pump inhibitors (e.g., Thapsigargin) or lysosomal pH modulators to study upstream regulation of SQSTM1 activation.
• Antioxidant response assessment: Quantification of ROS and NFE2L2 target gene expression following pathway perturbation.
• Autophagic flux measurement: Monitoring KEAP1 degradation and autophagosome formation via immunoblotting or fluorescence microscopy.

Researchers planning similar workflows may consult detailed protocols in internal articles covering apoptosis assay development and endoplasmic reticulum stress research.

Research Support Resources

To experimentally dissect the calcium signaling pathway and stress response mechanisms described above, researchers may employ SERCA pump inhibitors such as Thapsigargin (SKU B6614) from APExBIO. Thapsigargin (CAS 67526-95-8) is a potent, well-characterized tool for inducing ER stress and modulating intracellular calcium homeostasis, facilitating studies of autophagy, apoptosis, and oxidative stress signaling. For best practices and advanced workflows using Thapsigargin in apoptosis assay and endoplasmic reticulum stress research, see scenario-driven guidance in related articles.